IP Library › Assignment 022343/0269
Patent Assignment
Reel/Frame 022343/0269

Assignment of Assignor's Interest

Recorded: 2009-03-04 Pages: 6
Assignor
PDL BIOPHARMA, INC.
Executed: 2009-02-09
Assignee
FACET BIOTECH CORPORATION
1400 SEAPORT BLVD., REDWOOD CITY, CALIFORNIA, 94063
Covered Properties (4)
Antibodies Against Cancer Antigen TMEFF2 and Uses Thereof
Patent: 7,288,248 →
Application: 10/383,447 →
Publication: US 2004/0096392
Antibodies Against Cancer Antigen TMEFF2 and Uses Thereof
Patent: 7,785,816 →
Application: 11/837,333 →
Publication: US 2008/0044840
Antibodies Against Cancer Antigen TMEFF2 and Uses Thereof
Patent: 7,824,678 →
Application: 11/837,337 →
Publication: US 2008/0160012
Antibodies Against Cancer Antigen TMEFF2 and Uses Thereof
Patent: 7,674,883 →
Application: 11/855,073 →
Publication: US 2008/0175846
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 13, 2003
From: BHASKAR, VINAY; CALLE, AGUSTIN DE LA; LAW, DEBBIE; CARAS, INGRID
To: PROTEIN DESIGN LABS, INC.
Reel/Frame 014391/0598 →
Change of Name May 22, 2006
From: PROTEIN DESIGN LABS, INC.
To: PDL BIOPHARMA, INC.
Reel/Frame 017655/0436 →
Change of Name Dec 7, 2010
From: FACET BIOTECH CORPORATION
To: ABBOTT BIOTHERAPEUTICS CORP.
Reel/Frame 025445/0807 →
Change of Name Feb 18, 2013
From: ABBOTT BIOTHERAPEUTICS CORP
To: ABBVIE BIOTHERAPEUTICS INC.
Reel/Frame 029825/0070 →
Change of Name Dec 20, 2013
From: ABBOTT BIOTHERAPEUTICS CORP
To: ABBVIE BIOTHERAPEUTICS INC.
Reel/Frame 031834/0936 →